Irisys
-
Exton-Based Recro Pharma’s Acquisition of Competitor a ‘Transformative Transaction’
Exton-based Recro Pharma has acquired its West Coast competitor, Irisys of San Diego, in a cash and stock deal valued at roughly $50 million, writes…
Irisys

Exton-based Recro Pharma has acquired its West Coast competitor, Irisys of San Diego, in a cash and stock deal valued at roughly $50 million, writes…